FLUCYTOSINE

FLUCYTOSINE was reported 1418 times

FLUCYTOSINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMOEBIC BRAIN ABSCESS 2 0.2500
1 SPLENIC CANDIDIASIS 4 0.1739
2 NECROTISING FASCIITIS FUNGAL 4 0.1600
3 LYMPHADENITIS FUNGAL 3 0.1250
4 CEREBRAL VENTRICLE COLLAPSE 8 0.1067
5 MENINGEAL THICKENING 2 0.1053
6 BALAMUTHIA INFECTION 3 0.1034
7 RETICULOENDOTHELIAL DYSFUNCTION 1 0.1000
8 ENDOCARDITIS CANDIDA 7 0.0921
9 DISSEMINATED CRYPTOCOCCOSIS 66 0.0872
10 CENTRAL NERVOUS SYSTEM IMMUNE RECONSTITUTION INFLAMMATORY RESPONSE 3 0.0714
11 CRYPTOCOCCAL MENINGOENCEPHALITIS 9 0.0687
12 PHAEOHYPHOMYCOTIC BRAIN ABSCESS 2 0.0625
13 CRYPTOCOCCAL CUTANEOUS INFECTION 11 0.0604
14 PERICARDITIS ADHESIVE 2 0.0588
15 CRYPTOCOCCUS TEST POSITIVE 3 0.0577
16 ADJUSTED CALCIUM INCREASED 3 0.0566
17 MENINGITIS CRYPTOCOCCAL 98 0.0560
18 DISSEMINATED TRICHOSPORONOSIS 4 0.0556
19 ENCEPHALITIS PROTOZOAL 3 0.0536
20 NEUTROPHIL FUNCTION DISORDER 2 0.0526
21 TRICUSPID VALVE STENOSIS 3 0.0517
22 CANDIDA SEROLOGY POSITIVE 2 0.0488
23 NEUROCRYPTOCOCCOSIS 3 0.0484
24 PERIHEPATIC ABSCESS 4 0.0482
25 OSSEOUS CRYPTOCOCCOSIS 1 0.0476
26 ACANTHAMOEBA INFECTION 8 0.0426
27 INTRAOCULAR PRESSURE TEST 10 0.0417
28 CRYPTOCOCCOSIS 66 0.0405
29 LIVER TRANSPLANT FAILURE 2 0.0364
30 OSTEOMYELITIS FUNGAL 6 0.0359
31 FLUOROSIS 3 0.0349
32 CSF GLUCOSE DECREASED 4 0.0345
33 MENINGOENCEPHALITIS AMOEBIC 2 0.0345
34 WHITE BLOOD CELL ANALYSIS ABNORMAL 2 0.0323
35 OPTIC DISCS BLURRED 2 0.0312
36 PERICARDITIS FUNGAL 2 0.0303
37 MYOCARDITIS BACTERIAL 1 0.0303
38 MENINGITIS CANDIDA 2 0.0286
39 CRYPTOCOCCAL FUNGAEMIA 4 0.0280
40 XANTHOCHROMIA 1 0.0278
41 CSF SHUNT OPERATION 2 0.0278
42 ACANTHAMOEBA KERATITIS 1 0.0270
43 EYE INFECTION FUNGAL 10 0.0258
44 PNEUMONIA CRYPTOCOCCAL 24 0.0254
45 NEONATAL CANDIDA INFECTION 1 0.0233
46 PITUITARY INFARCTION 1 0.0233
47 APHAKIA 1 0.0213
48 SPINOCEREBELLAR DISORDER 1 0.0213
49 CEREBRAL FUNGAL INFECTION 6 0.0212
50 MYCOTIC ENDOPHTHALMITIS 4 0.0212
51 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 105 0.0211
52 FUNGAL ENDOCARDITIS 6 0.0199
53 CSF CULTURE POSITIVE 2 0.0189
54 PHAEOHYPHOMYCOSIS 9 0.0188
55 INFECTION PROTOZOAL 1 0.0175
56 AIDS ENCEPHALOPATHY 1 0.0172
57 IMMUNE RECONSTITUTION SYNDROME 22 0.0170
58 PREALBUMIN DECREASED 2 0.0167
59 TONIC POSTURING 1 0.0164
60 CEREBRAL ASPERGILLOSIS 10 0.0163
61 REVERSIBLE SPLENIAL LESION SYNDROME 1 0.0156
62 CENTRAL NERVOUS SYSTEM INFLAMMATION 5 0.0151
63 PERICARDIAL FIBROSIS 2 0.0144
64 MYOCARDIAC ABSCESS 1 0.0139
65 HEPATOSPLENIC CANDIDIASIS 2 0.0136
66 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 3 0.0129
67 DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS 1 0.0128
68 CHRONIC GRANULOMATOUS DISEASE 1 0.0122
69 RADIATION INTERACTION 1 0.0120
70 ABSCESS FUNGAL 2 0.0114
71 SCEDOSPORIUM INFECTION 8 0.0113
72 CSF PRESSURE INCREASED 3 0.0113
73 PROSTATIC ABSCESS 3 0.0109
74 CSF WHITE BLOOD CELL COUNT INCREASED 2 0.0105
75 CYTOMEGALOVIRUS ENTEROCOLITIS 8 0.0104
76 ATYPICAL MYCOBACTERIUM TEST POSITIVE 1 0.0103
77 VITH NERVE DISORDER 1 0.0099
78 PLEURAL MESOTHELIOMA MALIGNANT 3 0.0097
79 FUSOBACTERIUM INFECTION 1 0.0085
80 ANTICOAGULATION DRUG LEVEL DECREASED 1 0.0083
81 CANDIDA ENDOPHTHALMITIS 1 0.0082
82 MUSCLE ABSCESS 5 0.0080
83 LARYNGITIS FUNGAL 1 0.0078
84 DISSOCIATIVE AMNESIA 1 0.0077
85 CHEST WALL MASS 2 0.0077
86 HISTIOCYTOSIS 1 0.0075
87 CORYNEBACTERIUM INFECTION 4 0.0075
88 CENTRAL NERVOUS SYSTEM NECROSIS 2 0.0073
89 CEREBRAL CYST 5 0.0073
90 IIIRD NERVE DISORDER 1 0.0070
91 INFECTION IN AN IMMUNOCOMPROMISED HOST 5 0.0070
92 CLOSTRIDIUM DIFFICILE TOXIN TEST POSITIVE 1 0.0068
93 CANDIDA SEPSIS 6 0.0067
94 RESTRICTIVE CARDIOMYOPATHY 2 0.0066
95 GASTROENTERITIS ROTAVIRUS 2 0.0065
96 WOUND INFECTION PSEUDOMONAS 2 0.0064
97 BLASTOMYCOSIS 3 0.0062
98 CENTRAL NERVOUS SYSTEM VASCULITIS 3 0.0059
99 ACUTE DISSEMINATED ENCEPHALOMYELITIS 2 0.0058
100 CYTOMEGALOVIRUS ENTERITIS 2 0.0056
101 DRUG RESISTANCE MUTATION 1 0.0056
102 PANOPHTHALMITIS 1 0.0055
103 PULMONARY HILUM MASS 1 0.0053
104 PLEOCYTOSIS 3 0.0052
105 BRAIN ABSCESS 13 0.0051
106 PRODUCT INEFFECTIVE 4 0.0051
107 FUNGAEMIA 8 0.0051
108 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 3 0.0051
109 BONE ABSCESS 2 0.0049
110 RENAL ABSCESS 4 0.0049
111 HIV VIRAEMIA 1 0.0048
112 GEOTRICHUM INFECTION 1 0.0047
113 FRONTOTEMPORAL DEMENTIA 2 0.0047
114 CORNEAL INFECTION 1 0.0046
115 CENTRAL NERVOUS SYSTEM LUPUS 1 0.0045
116 POST INFLAMMATORY PIGMENTATION CHANGE 2 0.0044
117 SYSTEMIC CANDIDA 11 0.0044
118 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
119 NEPHROGENIC DIABETES INSIPIDUS 5 0.0043
120 ENCEPHALITIS 30 0.0043
121 POST PROCEDURAL OEDEMA 1 0.0043
122 CRANIOFACIAL DEFORMITY 1 0.0043
123 TRAUMATIC LIVER INJURY 1 0.0043
124 CORONARY ARTERY ANEURYSM 1 0.0043
125 MENINGITIS FUNGAL 1 0.0043
126 INTRAOCULAR PRESSURE TEST ABNORMAL 3 0.0043
127 DISSEMINATED ASPERGILLOSIS 2 0.0042
128 CARDIAC VALVE VEGETATION 2 0.0041
129 CEREBRAL VASOCONSTRICTION 3 0.0041
130 TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME 1 0.0040
131 LENTIGO 2 0.0040
132 SEPSIS SYNDROME 2 0.0040
133 FUNGAL PHARYNGITIS 1 0.0040
134 HERPES ZOSTER OTICUS 2 0.0039
135 INTRACRANIAL PRESSURE INCREASED 22 0.0039
136 INCISION SITE ABSCESS 1 0.0038
137 RESPIRATORY TRACT INFECTION FUNGAL 2 0.0038
138 PERFORATION 3 0.0037
139 EOSINOPHIL PERCENTAGE INCREASED 2 0.0037
140 ENCEPHALOMYELITIS 1 0.0037
141 LISTERIOSIS 4 0.0036
142 FUNGAL SEPSIS 3 0.0036
143 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 1 0.0036
144 RENAL CELL CARCINOMA STAGE UNSPECIFIED 2 0.0035
145 LENS DISORDER 1 0.0035
146 SUBCUTANEOUS NODULE 1 0.0035
147 MEDIASTINITIS 2 0.0034
148 CATHETER SITE HAEMATOMA 1 0.0034
149 SERUM SICKNESS 9 0.0032
150 HEPATOBILIARY DISEASE 2 0.0032
151 ANOREXIA NERVOSA 1 0.0031
152 GASTROENTERITIS BACTERIAL 1 0.0030
153 AUTONOMIC NEUROPATHY 3 0.0030
154 DRUG THERAPY 1 0.0029
155 BASAL GANGLIA INFARCTION 1 0.0029
156 NEUTROPENIC COLITIS 6 0.0029
157 MULTIPLE SYSTEM ATROPHY 1 0.0028
158 FUNGAL OESOPHAGITIS 2 0.0028
159 DERMATITIS DIAPER 2 0.0028
160 MONOCYTE PERCENTAGE INCREASED 2 0.0028
161 FAT EMBOLISM 1 0.0028
162 DELAYED GRAFT FUNCTION 2 0.0028
163 VASOGENIC CEREBRAL OEDEMA 2 0.0028
164 HEMIANOPIA HOMONYMOUS 2 0.0027
165 CHOROIDITIS 1 0.0027
166 HEPATIC INFARCTION 1 0.0027
167 LYMPHADENOPATHY MEDIASTINAL 5 0.0026
168 NEPHROPATHY TOXIC 29 0.0026
169 SYSTEMIC MYCOSIS 3 0.0026
170 PULMONARY MYCOSIS 2 0.0026
171 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
172 MYOCARDIAL OEDEMA 1 0.0025
173 EYE INFECTION TOXOPLASMAL 1 0.0025
174 ELECTROMECHANICAL DISSOCIATION 2 0.0025
175 VASCULAR ACCESS COMPLICATION 2 0.0025
176 SPUTUM CULTURE POSITIVE 2 0.0025
177 CEREBRAL ARTERY EMBOLISM 3 0.0025
178 UREAPLASMA INFECTION 1 0.0025
179 PAPILLOEDEMA 11 0.0024
180 CSF PROTEIN INCREASED 2 0.0024
181 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0024
182 RETINITIS 4 0.0023
183 LENTICULAR OPACITIES 1 0.0023
184 ENTEROCOCCAL INFECTION 11 0.0023
185 FACIAL NERVE DISORDER 1 0.0023
186 MULTIPLE-DRUG RESISTANCE 7 0.0023
187 MENINGITIS 15 0.0022
188 TRANSPLANT DYSFUNCTION 4 0.0022
189 PANCREATITIS HAEMORRHAGIC 1 0.0022
190 EATING DISORDER SYMPTOM 1 0.0022
191 MAGNESIUM DEFICIENCY 1 0.0021
192 MENINGISM 1 0.0021
193 METAPLASIA 1 0.0021
194 CRANIAL NERVE PARALYSIS 1 0.0021
195 MENINGITIS BACTERIAL 3 0.0021
196 INTERCEPTED DRUG PRESCRIBING ERROR 1 0.0020
197 BRAIN HERNIATION 6 0.0020
198 PNEUMONIA PSEUDOMONAL 3 0.0020
199 ACUTE PROMYELOCYTIC LEUKAEMIA 2 0.0019
200 POSTICTAL STATE 2 0.0019
201 BRAIN OEDEMA 24 0.0019
202 PULMONARY MUCORMYCOSIS 1 0.0019
203 HUMAN POLYOMAVIRUS INFECTION 1 0.0019
204 BLOOD GASES ABNORMAL 1 0.0019
205 OSTEOMYELITIS ACUTE 1 0.0018
206 HYDROCEPHALUS 10 0.0018
207 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
208 CLONUS 5 0.0018
209 HAEMORRHAGIC INFARCTION 1 0.0018
210 RETINOPATHY OF PREMATURITY 1 0.0018
211 ISCHAEMIC STROKE 32 0.0018
212 MENINGITIS TUBERCULOUS 1 0.0018
213 INTRAVASCULAR HAEMOLYSIS 1 0.0018
214 CEREBELLAR INFARCTION 3 0.0018
215 METASTASES TO MENINGES 4 0.0018
216 CEREBRAL VENTRICLE DILATATION 2 0.0017
217 DRUG RESISTANCE 44 0.0017
218 ASPERGILLUS INFECTION 11 0.0017
219 ANTEROGRADE AMNESIA 1 0.0017
220 BLOOD HIV RNA INCREASED 3 0.0017
221 PARADOXICAL DRUG REACTION 6 0.0016
222 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
223 NEURODEGENERATIVE DISORDER 1 0.0016
224 BLOOD BILIRUBIN DECREASED 1 0.0016
225 BLOOD UREA DECREASED 2 0.0016
226 HEPATOSPLENOMEGALY 4 0.0016
227 BRONCHOPULMONARY ASPERGILLOSIS 12 0.0015
228 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
229 LUNG OPACITY 4 0.0015
230 OESOPHAGEAL HAEMORRHAGE 2 0.0015
231 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
232 BONE DEFORMITY 1 0.0015
233 FUNGAL SKIN INFECTION 6 0.0015
234 CARBON DIOXIDE INCREASED 2 0.0015
235 CD4 LYMPHOCYTES DECREASED 3 0.0014
236 CENTRAL NERVOUS SYSTEM LESION 19 0.0014
237 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
238 CARDIOTOXICITY 12 0.0013
239 MENINGITIS ASEPTIC 6 0.0013
240 MULTIPLE DRUG THERAPY 1 0.0013
241 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
242 NEUROLOGICAL DECOMPENSATION 3 0.0013
243 BRAIN DEATH 4 0.0013
244 RETINAL PIGMENTATION 1 0.0013
245 PULMONARY VALVE STENOSIS 1 0.0013
246 SUPERIOR SAGITTAL SINUS THROMBOSIS 1 0.0013
247 CANDIDA INFECTION 21 0.0012
248 CYSTITIS HAEMORRHAGIC 5 0.0012
249 ENTEROCOCCAL SEPSIS 1 0.0012
250 OPTIC ATROPHY 2 0.0012
251 CEREBRAL INFARCTION 30 0.0012
252 PULMONARY NOCARDIOSIS 1 0.0012
253 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 4 0.0012
254 DRUG LEVEL INCREASED 20 0.0012
255 SEPTIC EMBOLUS 1 0.0012
256 JC VIRUS TEST POSITIVE 1 0.0012
257 VITAL FUNCTIONS ABNORMAL 1 0.0012
258 MILIARIA 2 0.0012
259 TENSION HEADACHE 5 0.0012
260 WOUND INFECTION STAPHYLOCOCCAL 2 0.0012
261 GRANULOMA 4 0.0012
262 PULMONARY CAVITATION 1 0.0011
263 AXONAL NEUROPATHY 1 0.0011
264 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
265 PROTEIN TOTAL INCREASED 3 0.0011
266 CEREBRAL VENOUS THROMBOSIS 2 0.0011
267 PNEUMONITIS 30 0.0011
268 MUCOSAL EROSION 1 0.0011
269 PNEUMONIA KLEBSIELLA 2 0.0011
270 OTOTOXICITY 2 0.0011
271 ACUTE PULMONARY OEDEMA 6 0.0011
272 RENAL TUBULAR DISORDER 3 0.0011
273 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30 0.0011
274 INTRACRANIAL MASS 1 0.0011
275 BRAIN STEM HAEMORRHAGE 1 0.0011
276 LIP DISORDER 2 0.0011
277 KLEBSIELLA BACTERAEMIA 1 0.0011
278 KIDNEY TRANSPLANT REJECTION 5 0.0010
279 IDIOSYNCRATIC DRUG REACTION 1 0.0010
280 PYELONEPHRITIS ACUTE 2 0.0010
281 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
282 BLOOD CULTURE POSITIVE 3 0.0010
283 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
284 KLEBSIELLA INFECTION 5 0.0010
285 GENOTYPE DRUG RESISTANCE TEST POSITIVE 1 0.0010
286 TONGUE BITING 2 0.0010
287 PARTIAL SEIZURES 5 0.0010
288 LUNG ABSCESS 2 0.0010
289 OEDEMA MUCOSAL 1 0.0010
290 ELECTROLYTE IMBALANCE 11 0.0009
291 ENTEROCOCCAL BACTERAEMIA 1 0.0009
292 FOETAL DISTRESS SYNDROME 2 0.0009
293 RENAL IMPAIRMENT 79 0.0009
294 PULMONARY MASS 14 0.0009
295 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
296 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
297 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
298 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
299 PSEUDOMEMBRANOUS COLITIS 2 0.0009
300 CYTOGENETIC ABNORMALITY 1 0.0009
301 DIABETIC RETINOPATHY 3 0.0009
302 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
303 VITH NERVE PARALYSIS 1 0.0009
304 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
305 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47 0.0009
306 LIP ULCERATION 1 0.0009
307 THROMBOPHLEBITIS 3 0.0009
308 RECTAL ULCER 1 0.0009
309 LYMPHOPENIA 12 0.0008
310 BRADYKINESIA 5 0.0008
311 INGROWING NAIL 2 0.0008
312 PULMONARY INFARCTION 2 0.0008
313 STREPTOCOCCAL SEPSIS 1 0.0008
314 OXYGEN CONSUMPTION INCREASED 2 0.0008
315 LACUNAR INFARCTION 2 0.0008
316 ENDOPHTHALMITIS 5 0.0008
317 HAEMATOLOGICAL INFECTION 2 0.0008
318 HEART INJURY 2 0.0008
319 AMPUTATION 1 0.0008
320 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
321 WHITE MATTER LESION 1 0.0008
322 PATHOGEN RESISTANCE 7 0.0008
323 ASPERGILLOSIS 1 0.0008
324 HYPOGAMMAGLOBULINAEMIA 5 0.0008
325 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
326 BEHAVIOUR DISORDER 4 0.0007
327 IMMUNODEFICIENCY 11 0.0007
328 STENOTROPHOMONAS INFECTION 1 0.0007
329 SKIN DEPIGMENTATION 1 0.0007
330 CORNEAL OPACITY 1 0.0007
331 MENINGITIS VIRAL 1 0.0007
332 HYPERCALCAEMIA 9 0.0007
333 IMMUNOGLOBULINS DECREASED 1 0.0007
334 VIRAEMIA 1 0.0007
335 PERITONEAL HAEMORRHAGE 1 0.0007
336 THROMBOTIC MICROANGIOPATHY 7 0.0007
337 HYPOMAGNESAEMIA 10 0.0007
338 HALLUCINATIONS, MIXED 3 0.0007
339 PRERENAL FAILURE 1 0.0007
340 NECK MASS 2 0.0007
341 CHOLECYSTITIS ACUTE 4 0.0007
342 PANCYTOPENIA 39 0.0007
343 HALLUCINATION, AUDITORY 11 0.0007
344 STRABISMUS 2 0.0007
345 HEART VALVE REPLACEMENT 1 0.0007
346 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
347 HYPERTHERMIA MALIGNANT 1 0.0007
348 METABOLIC ENCEPHALOPATHY 2 0.0007
349 THYROIDITIS 2 0.0007
350 HYPOAESTHESIA FACIAL 1 0.0007
351 SUSPECTED OFF LABEL USE 3 0.0007
352 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
353 FUNGAL PERITONITIS 1 0.0007
354 INFECTIOUS PLEURAL EFFUSION 1 0.0007
355 MYOGLOBIN BLOOD INCREASED 1 0.0007
356 CYTOPENIA 8 0.0007
357 PALLIATIVE CARE 1 0.0007
358 HYPOKALAEMIA 30 0.0006
359 MYELITIS 1 0.0006
360 BRONCHIAL DISORDER 1 0.0006
361 HISTOPLASMOSIS DISSEMINATED 1 0.0006
362 THERAPY NON-RESPONDER 28 0.0006
363 DISINHIBITION 1 0.0006
364 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
365 BRADYPHRENIA 4 0.0006
366 HEPARIN-INDUCED THROMBOCYTOPENIA 3 0.0006
367 OSTEOMYELITIS 11 0.0006
368 SYSTEMIC INFECTION 1 0.0006
369 CYTOMEGALOVIRUS INFECTION 10 0.0006
370 VACCINATION FAILURE 1 0.0006
371 ENTEROBACTER INFECTION 1 0.0006
372 BK VIRUS INFECTION 2 0.0006
373 HEPATORENAL SYNDROME 1 0.0006
374 ACUTE KIDNEY INJURY 88 0.0006
375 SEPTIC SHOCK 25 0.0006
376 PSEUDOMONAL SEPSIS 1 0.0006
377 HALLUCINATION, VISUAL 12 0.0006
378 TYPE I HYPERSENSITIVITY 2 0.0006
379 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
380 LUNG INFILTRATION 5 0.0006
381 FACIAL PARESIS 2 0.0006
382 CARDIOGENIC SHOCK 8 0.0006
383 LIVER TRANSPLANT REJECTION 1 0.0006
384 SPONDYLITIS 2 0.0005
385 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
386 VIRAL MUTATION IDENTIFIED 2 0.0005
387 AMYLASE INCREASED 2 0.0005
388 VENTRICULAR FIBRILLATION 6 0.0005
389 MENTAL STATUS CHANGES 15 0.0005
390 GRANULOCYTE COUNT DECREASED 1 0.0005
391 NECROSIS 3 0.0005
392 LEUKOENCEPHALOPATHY 2 0.0005
393 ANGIOPATHY 3 0.0005
394 STATUS EPILEPTICUS 6 0.0005
395 AUTOIMMUNE THYROIDITIS 2 0.0005
396 HYPOPROTEINAEMIA 1 0.0005
397 AORTIC ANEURYSM 4 0.0005
398 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
399 DRUG-INDUCED LIVER INJURY 16 0.0005
400 PNEUMONIA FUNGAL 2 0.0005
401 DIPLEGIA 1 0.0005
402 GENE MUTATION 1 0.0005
403 DEVICE RELATED SEPSIS 1 0.0005
404 RESPIRATORY FAILURE 36 0.0005
405 MUSCLE CONTRACTURE 1 0.0005
406 ARTHRITIS BACTERIAL 2 0.0005
407 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
408 SOCIAL PROBLEM 2 0.0005
409 MICROCYTIC ANAEMIA 1 0.0005
410 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
411 SKIN PLAQUE 4 0.0005
412 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
413 LYMPHOCYTOSIS 1 0.0005
414 MULTI-ORGAN FAILURE 8 0.0005
415 PRODUCT PRESCRIBING ISSUE 10 0.0005
416 RENAL TUBULAR ACIDOSIS 1 0.0005
417 CERVICAL DYSPLASIA 1 0.0005
418 MELANOCYTIC NAEVUS 2 0.0005
419 NOSOCOMIAL INFECTION 1 0.0005
420 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
421 ABDOMINAL ABSCESS 2 0.0005
422 BLOOD CREATINE INCREASED 2 0.0005
423 CHOLESTATIC LIVER INJURY 1 0.0004
424 ENCEPHALOPATHY 11 0.0004
425 VASCULAR DEVICE INFECTION 2 0.0004
426 CYTOMEGALOVIRUS COLITIS 1 0.0004
427 SHOCK 10 0.0004
428 RENAL FAILURE 57 0.0004
429 VITILIGO 1 0.0004
430 VENTRICULAR TACHYCARDIA 7 0.0004
431 PHOTOSENSITIVITY REACTION 7 0.0004
432 URINARY TRACT OBSTRUCTION 1 0.0004
433 CARDIAC TAMPONADE 2 0.0004
434 DIABETES INSIPIDUS 1 0.0004
435 VISUAL FIELD DEFECT 3 0.0004
436 HEMIPARESIS 7 0.0004
437 TREATMENT FAILURE 34 0.0004
438 TRANSPLANT FAILURE 1 0.0004
439 HYPOPHOSPHATAEMIA 3 0.0004
440 HYPERVOLAEMIA 2 0.0004
441 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
442 HYPERNATRAEMIA 2 0.0004
443 HYPERAMMONAEMIA 2 0.0004
444 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
445 DERMATITIS EXFOLIATIVE 2 0.0004
446 BRAIN INJURY 4 0.0004
447 VENTRICULAR HYPERTROPHY 1 0.0004
448 TOXIC SKIN ERUPTION 4 0.0004
449 PATHOLOGICAL FRACTURE 2 0.0004
450 HAEMODYNAMIC INSTABILITY 3 0.0004
451 SLUGGISHNESS 4 0.0004
452 NOCARDIOSIS 1 0.0004
453 ENDOCARDITIS 2 0.0004
454 BLOOD CHLORIDE DECREASED 1 0.0004
455 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
456 SKIN ULCER 10 0.0004
457 TORSADE DE POINTES 3 0.0004
458 VIROLOGIC FAILURE 2 0.0004
459 LIVER INJURY 9 0.0004
460 DRUG INTERACTION 58 0.0004
461 RASH MORBILLIFORM 1 0.0004
462 MACULE 1 0.0004
463 FUNGAL INFECTION 12 0.0004
464 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
465 PSYCHOMOTOR RETARDATION 1 0.0004
466 DRUG INEFFECTIVE 467 0.0004
467 NEUTROPENIA 48 0.0004
468 PSEUDOMONAS INFECTION 3 0.0003
469 COMA SCALE ABNORMAL 1 0.0003
470 HAEMOTHORAX 1 0.0003
471 BONE MARROW FAILURE 7 0.0003
472 VASCULITIS 4 0.0003
473 STRIDOR 1 0.0003
474 GROWTH RETARDATION 1 0.0003
475 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
476 HIV INFECTION 1 0.0003
477 MYELOFIBROSIS 1 0.0003
478 PNEUMONIA BACTERIAL 3 0.0003
479 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
480 DEVICE RELATED INFECTION 5 0.0003
481 PORTAL HYPERTENSION 1 0.0003
482 OLIGURIA 2 0.0003
483 SQUAMOUS CELL CARCINOMA 3 0.0003
484 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
485 PHOTOPSIA 2 0.0003
486 NON-CARDIAC CHEST PAIN 1 0.0003
487 HEPATOTOXICITY 7 0.0003
488 SUBSTANCE USE DISORDER 1 0.0003
489 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
490 CARDIO-RESPIRATORY ARREST 13 0.0003
491 ATELECTASIS 3 0.0003
492 SKIN EROSION 1 0.0003
493 HERPES SIMPLEX 2 0.0003
494 DEAFNESS NEUROSENSORY 1 0.0003
495 CARDIAC FAILURE ACUTE 2 0.0003
496 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
497 BLOOD CREATININE INCREASED 19 0.0003
498 JAUNDICE CHOLESTATIC 1 0.0003
499 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
500 MALNUTRITION 3 0.0003
501 IMPULSIVE BEHAVIOUR 1 0.0003
502 PROTEIN TOTAL DECREASED 1 0.0003
503 DISEASE PROGRESSION 31 0.0003
504 LIPASE INCREASED 2 0.0003
505 ACUTE RESPIRATORY FAILURE 5 0.0003
506 COGNITIVE DISORDER 12 0.0003
507 PROSTATOMEGALY 1 0.0003
508 RESPIRATORY ACIDOSIS 1 0.0003
509 PREMATURE DELIVERY 4 0.0003
510 OESOPHAGEAL CANDIDIASIS 1 0.0003
511 AZOTAEMIA 1 0.0003
512 CONDITION AGGRAVATED 76 0.0002
513 CANDIDIASIS 1 0.0002
514 HYPONATRAEMIA 14 0.0002
515 SENSORY LOSS 2 0.0002
516 ORGAN FAILURE 1 0.0002
517 RHINITIS 2 0.0002
518 RECURRENT CANCER 1 0.0002
519 EMBOLISM 2 0.0002
520 HEMIPLEGIA 2 0.0002
521 LUNG NEOPLASM 1 0.0002
522 ANAPHYLACTIC SHOCK 6 0.0002
523 ANURIA 2 0.0002
524 HEPATIC LESION 1 0.0002
525 IMMUNOSUPPRESSION 2 0.0002
526 TOXICITY TO VARIOUS AGENTS 38 0.0002
527 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
528 TACHYPNOEA 3 0.0002
529 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
530 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
531 ISCHAEMIA 1 0.0002
532 RESPIRATORY DISTRESS 6 0.0002
533 GRAND MAL CONVULSION 2 0.0002
534 PERICARDIAL EFFUSION 5 0.0002
535 MASS 3 0.0002
536 BACTERIAL INFECTION 4 0.0002
537 DIALYSIS 3 0.0002
538 COLITIS 8 0.0002
539 CARDIAC ARREST 17 0.0002
540 RENAL TUBULAR NECROSIS 2 0.0002
541 HYPOTONIA 2 0.0002
542 HEPATIC FAILURE 6 0.0002
543 DRUG LEVEL DECREASED 2 0.0002
544 CACHEXIA 1 0.0002
545 MYELOSUPPRESSION 7 0.0002
546 SKIN NECROSIS 1 0.0002
547 FAILURE TO THRIVE 1 0.0002
548 C-REACTIVE PROTEIN INCREASED 7 0.0002
549 APLASTIC ANAEMIA 1 0.0002
550 DERMATITIS 4 0.0002
551 FOLLICULITIS 2 0.0002
552 BLOOD LACTIC ACID INCREASED 1 0.0002
553 DRUG INTOLERANCE 18 0.0002
554 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
555 SKIN LESION 5 0.0002
556 DEAFNESS UNILATERAL 1 0.0002
557 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
558 PLEURAL EFFUSION 11 0.0002
559 BLOOD UREA INCREASED 3 0.0002
560 PANCREATITIS ACUTE 4 0.0002
561 PERIORBITAL SWELLING 1 0.0002
562 GRANULOCYTOPENIA 1 0.0002
563 EOSINOPHILIA 3 0.0002
564 SPLENOMEGALY 2 0.0002
565 HYPOXIA 6 0.0002
566 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
567 PSYCHOTIC DISORDER 5 0.0002
568 DRUG ERUPTION 3 0.0002
569 BACTERAEMIA 2 0.0002
570 PLEURISY 1 0.0002
571 COMA 8 0.0002
572 RHABDOMYOLYSIS 7 0.0002
573 PYREXIA 58 0.0002
574 HYPERLIPIDAEMIA 2 0.0002
575 RENAL FAILURE ACUTE 7 0.0002
576 ADRENAL INSUFFICIENCY 2 0.0002
577 TREATMENT NONCOMPLIANCE 9 0.0002
578 MUSCLE SPASTICITY 2 0.0002
579 GENERALISED OEDEMA 2 0.0002
580 ILEUS 2 0.0002
581 HEPATIC FUNCTION ABNORMAL 6 0.0002
582 NERVOUS SYSTEM DISORDER 5 0.0002
583 OFF LABEL USE 140 0.0002
584 HEPATIC CYTOLYSIS 2 0.0002
585 HYPOPHAGIA 4 0.0002
586 METABOLIC ACIDOSIS 5 0.0002
587 HEPATITIS 4 0.0002
588 ENTERITIS 1 0.0002
589 MUCOSAL INFLAMMATION 4 0.0002
590 THROMBOCYTOPENIA 17 0.0002
591 ORAL CANDIDIASIS 2 0.0002
592 IMMUNE SYSTEM DISORDER 2 0.0002
593 HAEMATOCRIT DECREASED 3 0.0002
594 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
595 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
596 UVEITIS 2 0.0001
597 DISEASE RECURRENCE 7 0.0001
598 DRUG TOXICITY 2 0.0001
599 ABNORMAL LOSS OF WEIGHT 1 0.0001
600 INFARCTION 1 0.0001
601 HYPERTRANSAMINASAEMIA 1 0.0001
602 PULMONARY TOXICITY 1 0.0001
603 SINUS TACHYCARDIA 2 0.0001
604 RETINAL HAEMORRHAGE 1 0.0001
605 METASTASIS 1 0.0001
606 NEUTROPENIC SEPSIS 1 0.0001
607 LEUKOPENIA 7 0.0001
608 CONVULSION 8 0.0001
609 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
610 LIVER FUNCTION TEST ABNORMAL 4 0.0001
611 RASH PUSTULAR 1 0.0001
612 GASTROENTERITIS 2 0.0001
613 ASCITES 4 0.0001
614 INFLAMMATION 7 0.0001
615 CARDIOMYOPATHY 2 0.0001
616 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
617 STEVENS-JOHNSON SYNDROME 3 0.0001
618 TRANSAMINASES INCREASED 3 0.0001
619 SEPSIS 15 0.0001
620 RASH PAPULAR 3 0.0001
621 ATRIAL FIBRILLATION 13 0.0001
622 HEPATIC ENZYME INCREASED 9 0.0001
623 OSTEOPENIA 2 0.0001
624 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
625 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
626 HYPERTHERMIA 1 0.0001
627 EPILEPSY 4 0.0001
628 ACIDOSIS 1 0.0001
629 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
630 LUNG INFECTION 2 0.0001
631 THERAPY PARTIAL RESPONDER 2 0.0001
632 HAEMORRHAGIC STROKE 1 0.0001
633 PULMONARY HAEMORRHAGE 1 0.0001
634 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
635 ABNORMAL BEHAVIOUR 5 0.0001
636 PNEUMOTHORAX 2 0.0001
637 BLOOD ALBUMIN DECREASED 1 0.0001
638 RENAL CYST 1 0.0001
639 LOW BIRTH WEIGHT BABY 1 0.0001
640 ABSCESS 2 0.0001
641 TRANSPLANT REJECTION 1 0.0001
642 BLOOD POTASSIUM INCREASED 2 0.0001
643 EYE DISORDER 4 0.0001
644 ESCHERICHIA INFECTION 1 0.0001
645 STAPHYLOCOCCAL INFECTION 4 0.0001
646 SECOND PRIMARY MALIGNANCY 1 0.0001
647 COAGULOPATHY 2 0.0001
648 CIRCULATORY COLLAPSE 2 0.0001
649 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
650 SKIN HYPERPIGMENTATION 1 0.0001
651 MYOPATHY 1 0.0001
652 LYMPHADENOPATHY 4 0.0001
653 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
654 PULMONARY OEDEMA 5 0.0001
655 BRAIN NEOPLASM 1 0.0001
656 IRON DEFICIENCY ANAEMIA 1 0.0001
657 HEPATIC ENCEPHALOPATHY 1 0.0001
658 FLANK PAIN 1 0.0001
659 PHOTOPHOBIA 2 0.0001
660 ABORTION INDUCED 1 0.0001
661 HAEMATOTOXICITY 1 0.0001
662 ANAEMIA 20 0.0001
663 SLEEP APNOEA SYNDROME 2 0.0001
664 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
665 PRESCRIBED OVERDOSE 2 0.0001
666 DIZZINESS POSTURAL 1 0.0001
667 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
668 RENAL INJURY 3 0.0001
669 GASTROINTESTINAL DISORDER 9 0.0001
670 VOMITING 47 0.0001
671 SALIVARY HYPERSECRETION 1 0.0001
672 PREMATURE BABY 3 0.0001
673 PERITONITIS BACTERIAL 1 0.0001
674 CONFUSIONAL STATE 16 0.0001
675 HYPOTHERMIA 1 0.0001
676 FEEDING DISORDER 2 0.0001
677 EYELID PTOSIS 1 0.0001
678 BLINDNESS 4 0.0001
679 SKELETAL INJURY 1 0.0001
680 POOR VENOUS ACCESS 1 0.0001
681 PETECHIAE 1 0.0001
682 JOINT DISLOCATION 1 0.0001
683 NIGHT SWEATS 3 0.0001
684 HEADACHE 58 0.0001
685 BIPOLAR DISORDER 1 0.0001
686 MENTAL DISORDER 4 0.0001
687 WOUND INFECTION 1 0.0001
688 FEBRILE NEUTROPENIA 6 0.0001
689 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
690 MEDICATION ERROR 5 0.0001
691 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
692 REBOUND EFFECT 1 0.0001
693 MYOCARDIAL ISCHAEMIA 1 0.0001
694 PNEUMONIA 28 0.0001
695 DELIRIUM 3 0.0001
696 POST PROCEDURAL HAEMORRHAGE 1 0.0001
697 COVID-19 PNEUMONIA 1 0.0001
698 DYSPHAGIA 8 0.0001
699 ATAXIA 1 0.0001
700 THERAPEUTIC RESPONSE DECREASED 5 0.0001
701 ACCIDENTAL OVERDOSE 3 0.0001
702 NO THERAPEUTIC RESPONSE 1 0.0001
703 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
704 CARDIOMEGALY 1 0.0001
705 CYST 1 0.0001
706 MUSCLE ATROPHY 1 0.0001
707 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
708 SEIZURE 9 0.0001
709 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
710 RESPIRATORY TRACT INFECTION 2 0.0001
711 NODULE 1 0.0001
712 ANHEDONIA 2 0.0001
713 SARS-COV-2 TEST POSITIVE 1 0.0001
714 DEPRESSED MOOD 4 0.0001
715 NEUTROPHIL COUNT DECREASED 3 0.0001
716 OSTEOPOROSIS 3 0.0001
717 RESPIRATORY ARREST 2 0.0001
718 CARPAL TUNNEL SYNDROME 1 0.0001
719 BRONCHOSPASM 1 0.0001
720 MYELODYSPLASTIC SYNDROME 1 0.0001
721 INFECTION 10 0.0001
722 DECREASED APPETITE 16 0.0001
723 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
724 DYSGEUSIA 5 0.0001
725 BLOOD POTASSIUM DECREASED 2 0.0001
726 APHASIA 2 0.0001
727 INSURANCE ISSUE 1 0.0001
728 LYMPHOMA 1 0.0001
729 MUSCULOSKELETAL CHEST PAIN 1 0.0001
730 DELUSION 1 0.0001
731 ACUTE MYELOID LEUKAEMIA 1 0.0001
732 PRODUCT USE ISSUE 12 0.0001
733 PRODUCT USE COMPLAINT 1 0.0001
734 ARRHYTHMIA 3 0.0001
735 PULMONARY EMBOLISM 6 0.0001
736 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
737 MOVEMENT DISORDER 2 0.0001
738 CARDIAC FAILURE 5 0.0001
739 HYPOGLYCAEMIA 3 0.0001
740 MULTIPLE FRACTURES 1 0.0001
741 VISUAL ACUITY REDUCED 2 0.0001
742 URINARY TRACT INFECTION 10 0.0001
743 ORTHOSTATIC HYPOTENSION 1 0.0001
744 HYPERKALAEMIA 2 0.0001
745 NAUSEA 45 0.0001
746 PANCREATITIS 3 0.0001
747 LYMPHOCYTE COUNT DECREASED 1 0.0001
748 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
749 PLATELET COUNT DECREASED 6 0.0001
750 TACHYCARDIA 5 0.0001
751 CEREBRAL HAEMORRHAGE 2 0.0001
752 LEUKOCYTOSIS 1 0.0001
753 HYPOTENSION 11 0.0001
754 HEPATIC STEATOSIS 1 0.0001
755 THINKING ABNORMAL 1 0.0001
756 BLISTER 3 0.0001
757 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
758 INTESTINAL OBSTRUCTION 2 0.0001
759 BLOOD SODIUM DECREASED 1 0.0001
760 GASTRIC ULCER 1 0.0001
761 LETHARGY 3 0.0001
762 CHOLESTASIS 1 0.0001
763 DRUG PRESCRIBING ERROR 1 0.0001
764 ABDOMINAL PAIN 12 0.0001
765 EAR PAIN 1 0.0001
766 DIARRHOEA 33 0.0001
767 KIDNEY INFECTION 1 0.0001
768 PREGNANCY 1 0.0000
769 CYTOKINE RELEASE SYNDROME 1 0.0000
770 CHEST PAIN 9 0.0000
771 EXPOSURE DURING PREGNANCY 3 0.0000
772 DRUG ABUSE 4 0.0000
773 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
774 RETCHING 1 0.0000
775 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
776 LIVER DISORDER 2 0.0000
777 PARAESTHESIA 7 0.0000
778 MUSCULAR WEAKNESS 5 0.0000
779 RENAL DISORDER 2 0.0000
780 BLOOD GLUCOSE DECREASED 2 0.0000
781 PRURITUS 16 0.0000
782 INTERSTITIAL LUNG DISEASE 2 0.0000
783 LUNG DISORDER 2 0.0000
784 CELLULITIS 2 0.0000
785 LOSS OF CONSCIOUSNESS 5 0.0000
786 THERAPY CESSATION 2 0.0000
787 UNRESPONSIVE TO STIMULI 1 0.0000
788 DIPLOPIA 1 0.0000
789 ABDOMINAL DISTENSION 4 0.0000
790 SPEECH DISORDER 2 0.0000
791 FEAR 1 0.0000
792 JAUNDICE 1 0.0000
793 FREQUENT BOWEL MOVEMENTS 1 0.0000
794 BLOOD BILIRUBIN INCREASED 1 0.0000
795 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
796 HAEMOPTYSIS 1 0.0000
797 DEMENTIA 1 0.0000
798 SKIN EXFOLIATION 3 0.0000
799 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
800 INTENTIONAL DOSE OMISSION 1 0.0000
801 DEATH 30 0.0000
802 HERPES ZOSTER 2 0.0000
803 MUSCULOSKELETAL STIFFNESS 3 0.0000
804 NASAL CONGESTION 2 0.0000
805 LABORATORY TEST ABNORMAL 1 0.0000
806 URINARY INCONTINENCE 1 0.0000
807 CATARACT 2 0.0000
808 HYPOAESTHESIA 5 0.0000
809 NO ADVERSE EVENT 6 0.0000
810 HYPERTENSION 7 0.0000
811 SWELLING 3 0.0000
812 BONE DENSITY DECREASED 1 0.0000
813 HIP FRACTURE 1 0.0000
814 PAIN IN EXTREMITY 9 0.0000
815 HEART RATE INCREASED 3 0.0000
816 VIRAL INFECTION 1 0.0000
817 SOMNOLENCE 6 0.0000
818 TYPE 2 DIABETES MELLITUS 1 0.0000
819 HAEMOGLOBIN DECREASED 3 0.0000
820 VISION BLURRED 4 0.0000
821 HAEMORRHAGE 3 0.0000
822 COVID-19 5 0.0000
823 HEART RATE DECREASED 1 0.0000
824 THERAPY INTERRUPTED 2 0.0000
825 HYPERGLYCAEMIA 1 0.0000
826 AGITATION 2 0.0000
827 FALL 9 0.0000
828 DYSARTHRIA 1 0.0000
829 UNEVALUABLE EVENT 2 0.0000
830 CHRONIC KIDNEY DISEASE 2 0.0000
831 DIABETES MELLITUS 2 0.0000
832 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
833 HOSPITALISATION 4 0.0000
834 PLASMA CELL MYELOMA 1 0.0000
835 CHILLS 3 0.0000
836 DISORIENTATION 1 0.0000
837 RASH 11 0.0000
838 WEIGHT DECREASED 7 0.0000
839 ABORTION SPONTANEOUS 1 0.0000
840 EMOTIONAL DISTRESS 3 0.0000
841 DYSKINESIA 1 0.0000
842 INFLUENZA LIKE ILLNESS 2 0.0000
843 HYPOACUSIS 1 0.0000
844 OVERDOSE 5 0.0000
845 DEVICE LEAKAGE 1 0.0000
846 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
847 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
848 ADVERSE DRUG REACTION 2 0.0000
849 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
850 TINNITUS 1 0.0000
851 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
852 BACK PAIN 5 0.0000
853 NEUROPATHY PERIPHERAL 2 0.0000
854 PRODUCTIVE COUGH 1 0.0000
855 RASH ERYTHEMATOUS 1 0.0000
856 ALOPECIA 4 0.0000
857 DRY EYE 1 0.0000
858 SINUSITIS 2 0.0000
859 ERYTHEMA 4 0.0000
860 BRADYCARDIA 1 0.0000
861 DRUG EFFECT DECREASED 1 0.0000
862 OEDEMA 1 0.0000
863 HAEMATOCHEZIA 1 0.0000
864 DIZZINESS 9 0.0000
865 EYE PAIN 1 0.0000
866 ANXIETY 5 0.0000
867 PRODUCT SUBSTITUTION ISSUE 1 0.0000
868 BONE PAIN 1 0.0000
869 SURGERY 1 0.0000
870 WHEEZING 1 0.0000
871 JOINT SWELLING 2 0.0000
872 STOMATITIS 1 0.0000
873 OEDEMA PERIPHERAL 2 0.0000
874 VERTIGO 1 0.0000
875 DISCOMFORT 1 0.0000
876 VISUAL IMPAIRMENT 2 0.0000
877 ASTHENIA 6 0.0000
878 INTENTIONAL OVERDOSE 1 0.0000
879 INFUSION RELATED REACTION 1 0.0000
880 BLOOD PRESSURE DECREASED 1 0.0000
881 PRODUCT QUALITY ISSUE 2 0.0000
882 MEMORY IMPAIRMENT 2 0.0000
883 COUGH 4 0.0000
884 DEVICE MALFUNCTION 1 0.0000
885 INJURY 1 0.0000
886 DYSPNOEA 8 0.0000
887 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
888 UNDERDOSE 1 0.0000
889 EPISTAXIS 1 0.0000
890 HALLUCINATION 1 0.0000
891 HOT FLUSH 1 0.0000
892 INJECTION SITE BRUISING 1 0.0000
893 CARDIAC FAILURE CONGESTIVE 1 0.0000
894 DRY MOUTH 1 0.0000
895 TREMOR 2 0.0000
896 ARTHRALGIA 5 0.0000
897 ABDOMINAL DISCOMFORT 2 0.0000
898 BALANCE DISORDER 1 0.0000
899 FATIGUE 9 0.0000
900 INTENTIONAL PRODUCT MISUSE 1 0.0000
901 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
902 NASOPHARYNGITIS 2 0.0000
903 MIGRAINE 1 0.0000
904 GAIT DISTURBANCE 2 0.0000
905 SYNCOPE 1 0.0000
906 FLUSHING 1 0.0000
907 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
908 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
909 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
910 MALAISE 4 0.0000
911 INCORRECT DOSE ADMINISTERED 2 0.0000
912 HYPERHIDROSIS 1 0.0000
913 PSORIASIS 1 0.0000
914 DEHYDRATION 1 0.0000
915 DRY SKIN 1 0.0000
916 BLOOD PRESSURE INCREASED 1 0.0000
917 PAIN 4 0.0000
918 PERIPHERAL SWELLING 1 0.0000
919 URTICARIA 1 0.0000
920 MYALGIA 1 0.0000
921 HYPERSENSITIVITY 1 0.0000
922 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
923 ABDOMINAL PAIN UPPER 1 0.0000
924 CONSTIPATION 1 0.0000
925 DEPRESSION 1 0.0000
926 PRODUCT DOSE OMISSION ISSUE 1 0.0000